Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: Prospects for personalized medicine

Prostate cancer (PrCa) genomic heterogeneity causes resistance to therapies such as androgen dep‑ rivation. Such heterogeneity can be deciphered in the context of evolutionary principles, but current clinical trials do not include evolution as an essential feature.